CRP and non-small cell lung carcinoma: For a rather homogeneous group of 89 stage III NSCLC treated with concurrent or sequential radiochemotherapy between 2006 and 2013, Mitsuyoshi et al. found a larger CRP level ≥ 0.3 mg/dl to be associated with shorter OS56.